Prediction of Progression-Free Survival in Patients With Advanced, Well-Differentiated, Neuroendocrine Tumors Being Treated With a Somatostatin Analog: The GETNE-TRASGU Study

1. Carmona-Bayonas, A.
2. Jiménez-Fonseca, P.
3. Lamarca, Á.
4. Barriuso, J.
5. Castaño, Á.
6. Benavent, M.
7. Alonso, V.
8. Riesco-Martínez, M.D.C.
9. Alonso-Gordoa, T.
10. Custodio, A.
11. Sánchez Cánovas, M.
12. Hernando Cubero, J.
13. López, C.
14. Lacasta, A.
15. Fernández Montes, A.
16. Marazuela, M.
17. Crespo, G.
18. Escudero, P.
19. Diaz, J.Á.
20. Feliciangeli, E.
21. Gallego, J.
22. Llanos, M.
23. Segura, Á.
24. Vilardell, F.
25. Percovich, J.C.
26. Grande, E.
27. Capdevila, J.
28. Valle, J.W.
29. García-Carbonero, R.
30. Show all authors +

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1200/JCO.19.00980 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus